Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
Zezheng LiuWenquan LiangDawei KangQingjing ChenZhicong OuyangHuibo YanBin HuangDadi JinYinkui ChenQingchu LiPublished in: Clinical interventions in aging (2020)
Our study illustrates the roles of Cxcl9 in inhibiting bone formation and stimulating bone resorption in osteoporotic bone, therefore providing a possible therapeutic target to the treatment of postmenopausal osteoporosis.